Pfizer Sinks on Weak 2024 Forecasts, COVID Vaccine Slowdown
On Wednesday, Pfizer’s (PFE) stock plummeted to a 10-year low after the US drugmaker cut 2024 sales guidance amid declining COVID-19 vaccine demand. Pfizer shares retreated by -6.72% to $26.66